[AVGR] Avinger, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 4.1 Change: 0.1 (2.5%)
Ext. hours: Change: 0 (0%)

chart AVGR

Refresh chart

Strongest Trends Summary For AVGR

AVGR is in the long-term down -100% below S&P in 7 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-3.01 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -32.05% Sales Growth - Q/Q-32.05% P/E-0.16
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-23.22% ROE-43.56% ROI-27.02%
Current Ratio6.8 Quick Ratio6.44 Long Term Debt/Equity0.4 Debt Ratio0.26
Gross Margin44.58% Operating Margin-317.79% Net Profit Margin-359.47% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities65.22 M Cash From Investing Activities-210 K Cash From Operating Activities-7.92 M Gross Profit800 K
Net Profit-10.42 M Operating Profit-9.43 M Total Assets79.89 M Total Current Assets76.37 M
Total Current Liabilities11.23 M Total Debt29.56 M Total Liabilities37.3 M Total Revenue2.09 M
Technical Data
High 52 week10.5 Low 52 week0.19 Last close1.79 Last change1.7%
RSI40.78 Average true range0.27 Beta4.41 Volume120.46 K
Simple moving average 20 days-15.64% Simple moving average 50 days-44.71% Simple moving average 200 days-40.47%
Performance Data
Performance Week-4.28% Performance Month-37.19% Performance Quart-69.19% Performance Half426.47%
Performance Year7.19% Performance Year-to-date496.67% Volatility daily8.63% Volatility weekly19.31%
Volatility monthly39.57% Volatility yearly137.07% Relative Volume348.92% Average Volume300.66 K
New High New Low

News

2020-05-29 12:42:49 | Hedge Funds Are Warming Up To Avinger Inc AVGR

2020-05-28 12:00:04 | Avinger AVGR Upgraded to Strong Buy: Here's Why

2020-05-20 08:30:00 | Avinger Announces 510k Filing of Ocelaris Next Generation Image-guided CTO Crossing System

2020-05-17 17:24:44 | Edited Transcript of AVGR earnings conference call or presentation 13-May-20 8:30pm GMT

2020-05-13 16:01:00 | Avinger Reports First Quarter 2020 Financial Results

2020-05-07 09:00:00 | Avinger to Announce First Quarter 2020 Results on May 13, 2020

2020-05-06 12:00:00 | Avinger Announces Exercise and Closing of Underwriter's Over-Allotment Offering

2020-04-30 11:17:00 | Avinger Closes $3.15 Million Equity Offering

2020-04-27 21:25:00 | Avinger Prices $3.15 Million Underwritten Public Offering of Common Stock

2020-04-17 12:00:04 | Avinger AVGR Upgraded to Buy: Here's Why

2020-04-15 09:00:00 | Avinger Reports Preliminary First Quarter 2020 Revenue Results

2020-03-13 11:17:02 | Edited Transcript of AVGR earnings conference call or presentation 5-Mar-20 9:30pm GMT

2020-03-05 16:05:00 | Avinger Reports Fourth Quarter 2019 Financial Results

2020-03-05 14:30:00 | Avinger, Inc. to Host Earnings Call

2020-02-27 08:00:00 | Avinger to Announce Fourth Quarter 2019 Financial Results on March 5, 2020

2020-02-25 08:30:00 | Avinger Announces Publication of SCAN Clinical Study in Peer-Reviewed Journal

2020-02-04 08:00:00 | Avinger's Pantheris Featured in Live Case Transmission at LINC 2020

2020-01-31 16:01:00 | Avinger Closes $4.5 Million Equity Offering

2020-01-30 08:30:00 | Avinger Announces the Passing of Director Donald A. Lucas

2020-01-28 20:05:00 | Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock

2020-01-23 08:00:00 | Avinger Enrolls First Patient in IMAGE-BTK Clinical Study Evaluating Safety and Efficacy Endpoints for Pantheris SV

2020-01-19 07:42:57 | Is Avinger, Inc. NASDAQ:AVGR A Volatile Stock?

2020-01-09 08:30:00 | Avinger Announces Successful First Procedures in Europe with Ocelaris Chronic Total Occlusion CTO Image-Guided Crossing Device

2019-12-17 08:30:00 | Avinger Receives CE Marking for Ocelaris, a Next-Generation Image-Guided CTO Crossing System

2019-12-16 08:30:00 | Avinger Appoints Healthcare Veteran Tamara Elias, MD, to Board of Directors

2019-11-21 09:43:57 | Edited Transcript of AVGR earnings conference call or presentation 5-Nov-19 9:30pm GMT

2019-11-18 09:18:02 | Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys

2019-11-15 07:06:12 | What Bargain Hunting? Tap 5 Stocks With Rising P/E

2019-11-05 16:01:00 | Avinger Reports Third Quarter 2019 Financial Results

2019-10-31 06:52:10 | Try Rising P/E Investing With 5 Top-Ranked Stocks

2019-10-29 09:00:00 | Avinger to Announce Third Quarter 2019 Financial Results on November 5, 2019

2019-10-24 09:00:01 | Avinger AVGR Upgraded to Strong Buy: What Does It Mean for the Stock?

2019-10-24 07:31:11 | Top Ranked Momentum Stocks to Buy for October 24th

2019-10-18 10:23:24 | These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year

2019-10-17 07:27:11 | Go Beyond Bargains: Play 5 Stocks With Rising P/E Instead

2019-10-09 08:00:00 | Avinger Expands US Reach with Seven New Accounts in Third Quarter

2019-09-18 08:00:00 | Avinger Announces Full Commercial Launch of Pantheris SV

2019-09-17 08:00:00 | Avinger to Present at Ladenburg Thalmann Healthcare Conference on September 24

2019-09-10 08:00:00 | Avinger Announces Commercial Launch and First Patients Treated in Hong Kong

2019-09-04 08:30:00 | Avinger Supports Peripheral Artery Disease PAD Awareness Month with Physician and Patient Programs in September

2019-08-29 08:00:00 | Avinger Announces 50th Patient Treated in Pantheris SV Initial Launch

2019-08-26 16:02:00 | Avinger Closes $4.5 Million Equity Offering

2019-08-21 21:00:00 | Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock

2019-08-21 16:15:00 | Avinger Announces Proposed Underwritten Public Offering of Common Stock

2019-08-19 07:00:00 | Avinger Announces Presentations by Key Opinion Leaders at AMP 2019 Clinical Conference

2019-08-02 17:41:56 | Edited Transcript of AVGR earnings conference call or presentation 31-Jul-19 8:30pm GMT

2019-07-31 16:01:00 | Avinger Reports 26% Sequential Revenue Growth in Second Quarter 2019

2019-07-29 08:00:00 | Avinger Announces Pantheris SV Limited Launch and Successful Treatment of First Patients in the United States

2019-07-26 09:00:00 | Avinger to Announce Second Quarter 2019 Financial Results on July 31, 2019

2019-07-16 08:00:00 | Avinger Announces Presentations by Key Opinion Leaders at CVC 2019